The Bethel Musculoskeletal Research Center (BMRC) BioBank: Establishing a Standardized, Reproducible Platform for Basic, Translational, and Clinical Musculoskeletal Research - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Bethel Musculoskeletal Research Center (BMRC) BioBank: Building a Standardized, Reproducible Resource for Basic, Translational, and Clinical Research in Musculoskeletal Health

  • By

  • Joon Y. Lee

  • Ryan T. Lin

  • Jacob Weinberg

  • Christopher Gonzalez

  • John Bonamer

  • MaCalus V. Hogan

  • Melissa Yunting Tang

  • Peter Alexander

  • J. Paulo Coelho

  • BMRC Surgical Collaborators

  • Nam Vo

  • November 17, 2026

Share

Clinical Scorecard: The Bethel Musculoskeletal Research Center (BMRC) BioBank

At a Glance

CategoryDetail
ConditionMusculoskeletal health research and biobanking
Key MechanismsLinks surgical biospecimen metadata with longitudinal EHR-derived clinical information and imaging in a secure research enclave; prospective molecular and multi-omics datasets are also part of the platform.
Target PopulationPatients undergoing orthopaedic surgery across spine, joints, hand and upper extremity, foot and ankle, and pediatric orthopaedics.
Care SettingAcademic orthopaedic research at the University of Pittsburgh, using a secure, cloud-based research enclave.

Key Highlights

  • The BMRC BioBank integrates governance, specimen operations, and data infrastructure in a platform designed for replication across orthopaedic subspecialties.
  • SOPs, specified quality-control thresholds, and a three-tier grading system support consistent specimen collection and processing.
  • By August 7, 2026, the repository included 502 patients and 17,929 aliquots, connected to longitudinal clinical records and 1,110 imaging studies.
  • Managed virtual environments allow investigators to analyze integrated data while information remains within the secure enclave.
  • The platform has received requests for both focused inquiries and dataset-wide analyses across orthopaedic subspecialties.
  • The source reports enrollment accelerating to approximately seven patients weekly and projects a 1,000-patient cohort by the end of 2027 or early 2028.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • The source states that incomplete, nonstandardized musculoskeletal datasets can make findings difficult to reproduce or compare across institutions.
        • The source states that pre-analytical variables can affect downstream analytical validity and describes recording these variables within the BioBank framework.

        Patient & Prescribing Data

        From October 2024 through August 7, 2026, the reported cohort included 502 patients (266 females, 236 males; mean age 60.9 years). The source separately reports a pediatric orthopaedic component of 22 patients and 409 aliquots; it does not clarify whether those patients are included in the 502.

        The article describes a research biobank, not a treatment or prescribing intervention. It reports surgical tissue and blood specimens connected with clinical records and imaging, with prospective molecular datasets included in the platform.

        Clinical Best Practices

        • The BMRC framework uses IRB-approved consent, material transfer and data use agreements, and HIPAA-compliant infrastructure.
        • The framework identifies tissue types, processing protocols, and pre-analytical variables.
        • The BioBank uses SOP-directed collection and processing, specified QC thresholds, and specimen grading.
        • The platform links specimen metadata with longitudinal clinical records and imaging within a governed secure environment.

        Related Resources & Content

          Original Source(s)

          Related Content